MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0070780
Synryn Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.91 Cr
▼ 3% YoY
Net profit · FY 2025
₹15.32 Lakh
Net margin 5.3%
EBITDA · FY 2025
₹30.11 Lakh
EBITDA margin 10.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Synryn Pharma Private Limited
Data last updated:
Synryn Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 20 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73200TG2018PTC126873. Its GSTIN is 36ABACS8421K1Z5 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Keerthi and Venkat Reddy Sappidi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No 42 – 610 Mj Colony Moula Ali, Hyderabad, Telangana, India – 500040.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.91 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹15.32 Lakh (net margin 5.3%) and EBITDA of ₹30.11 Lakh (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 29% over five years.
The company is associated with 1 brand: Synryn Pharma.
Synryn Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0070780). For more details, the company can be reached via its website synryn.com.
Company details
CIN U73200TG2018PTC126873
Registration Number 126873
Incorporation Date 20 September 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0070780
Recognitions & Rankings of Synryn Pharma
Contact details
Synryn Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is synryn.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH.No 42 – 610 Mj Colony Moula Ali, Hyderabad, Telangana, India – 500040
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Synryn Pharma Private Limited, buy the company report.
Comprehensive company report
Synryn Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Synryn Pharma operates one associated brand: Synryn Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures specialty chemicals and intermediates with contract R&D services. | synryn.com |
Business activity
The main business activity of Synryn Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Synryn Pharma Private Limited, buy the company report.
Financials of Synryn Pharma Private Limited
FY 2025 filings availableSynryn Pharma Private Limited reported revenue of ₹2.91 Cr (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹2.91 Cr ▼ 3%
Net profit · FY 2025
₹15.32 Lakh margin 5.3%
EBITDA · FY 2025
₹30.11 Lakh margin 10.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 29%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 65%
5 years · compounded
▲ 51%
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 29%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synryn Pharma Private Limited, buy the company report.
Board of directors of Synryn Pharma Private Limited
Synryn Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Keerthi | Director | 25 Feb 2019 | 7 Years 7 Months | Current |
| Venkat Reddy Sappidi | Additional Director | 06 Feb 2020 | 6 Years 8 Months | Current |
Auditor
Synryn Pharma Private Limited is audited by C S REDDY & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C S REDDY & CO | FY 2019 | 016317S |
Shareholding
The shareholding of Synryn Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Synryn Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Synryn Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synryn Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Synryn Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABACS8421K1Z5 | Telangana | Active | 01 Oct 2018 |
To see the full GST registrations and return filing status of Synryn Pharma Private Limited, buy the company report.
Recent activity
Synryn Pharma Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Ravinder Reddy Tippanna ceased to be Additional Director on 04 Sep 2021.
AGM
Synryn Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Synryn Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Ravinder Reddy Tippanna ceased to be Additional Director.
Ceased
Narsaiah Chinthala ceased to be Director.
Appointed
Venkat Reddy Sappidi was appointed as Additional Director.
Appointed
Ravi Keerthi was appointed as Director.
Ceased
Vamshi Kiran Adelapuram ceased to be Director.
Incorporation
20 Sep 2018
Synryn Pharma Private Limited was registered on 20 Sep 2018 with Roc Hyderabad & aged 8 years 1 month as per MCA records.
Frequently asked questions
Synryn Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 20 September 2018 (8+ years old) and is registered under CIN U73200TG2018PTC126873.
Synryn Pharma has 2 current directors:
- Ravi Keerthi - Director
- Venkat Reddy Sappidi - Additional Director
The latest financial statements of Synryn Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Synryn Pharma is 36ABACS8421K1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of Synryn Pharma is U73200TG2018PTC126873. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synryn Pharma was incorporated on 20 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Ravinder Reddy Tippanna ceased to be Additional Director on 04 Sep 2021. Narsaiah Chinthala ceased to be Director on 05 Jun 2020. Venkat Reddy Sappidi was appointed as Additional Director on 06 Feb 2020. Synryn Pharma has 5 board changes on record in total.
Yes, Synryn Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0070780).
Synryn Pharma can be reached through the website synryn.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Synryn Pharma is at H.No 42 – 610 Mj Colony Moula Ali, Hyderabad, Telangana, India – 500040.